Goldman Sachs’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.41B | Buy |
18,057,047
+1,716,975
| +11% | +$400M | 0.51% | 24 |
|
|
2025
Q4 | $3.38B | Buy |
16,340,072
+3,230,328
| +25% | +$639M | 0.41% | 27 |
|
|
2025
Q3 | $2.43B | Buy |
13,109,744
+967,800
| +8% | +$166M | 0.3% | 43 |
|
|
2025
Q2 | $1.85B | Buy |
12,141,944
+480,741
| +4% | +$73.9M | 0.25% | 55 |
|
|
2025
Q1 | $1.93B | Buy |
11,661,203
+401,516
| +4% | +$62.8M | 0.31% | 47 |
|
|
2024
Q4 | $1.63B | Sell |
11,259,687
-2,125,236
| -16% | -$329M | 0.26% | 62 |
|
|
2024
Q3 | $2.17B | Buy |
13,384,923
+2,766,851
| +26% | +$441M | 0.35% | 44 |
|
|
2024
Q2 | $1.55B | Buy |
10,618,072
+261,389
| +3% | +$38.9M | 0.26% | 60 |
|
|
2024
Q1 | $1.64B | Sell |
10,356,683
-2,809,981
| -21% | -$447M | 0.29% | 53 |
|
|
2023
Q4 | $2.06B | Buy |
13,166,664
+504,835
| +4% | +$77.4M | 0.38% | 38 |
|
|
2023
Q3 | $1.97B | Buy |
12,661,829
+2,387,591
| +23% | +$394M | 0.42% | 32 |
|
|
2023
Q2 | $1.7B | Sell |
10,274,238
-1,232,525
| -11% | -$199M | 0.36% | 39 |
|
|
2023
Q1 | $1.78B | Sell |
11,506,763
-1,061,987
| -8% | -$171M | 0.41% | 34 |
|
|
2022
Q4 | $2.22B | Buy |
12,568,750
+600,752
| +5% | +$104M | 0.54% | 17 |
|
|
2022
Q3 | $1.96B | Buy |
11,967,998
+37,263
| +0.3% | +$6.31M | 0.49% | 25 |
|
|
2022
Q2 | $2.12B | Buy |
11,930,735
+294,385
| +3% | +$52.5M | 0.53% | 23 |
|
|
2022
Q1 | $2.06B | Buy |
11,636,350
+120,234
| +1% | +$20.5M | 0.43% | 28 |
|
|
2021
Q4 | $1.97B | Sell |
11,516,116
-1,857,539
| -14% | -$304M | 0.39% | 30 |
|
|
2021
Q3 | $2.16B | Buy |
13,373,655
+712,815
| +6% | +$122M | 0.46% | 29 |
|
|
2021
Q2 | $2.09B | Sell |
12,660,840
-195,160
| -2% | -$32.3M | 0.47% | 27 |
|
|
2021
Q1 | $2.11B | Buy |
12,856,000
+2,327,231
| +22% | +$377M | 0.53% | 24 |
|
|
2020
Q4 | $1.66B | Buy |
10,528,769
+254,339
| +2% | +$37.5M | 0.43% | 27 |
|
|
2020
Q3 | $1.53B | Sell |
10,274,430
-1,789,448
| -15% | -$265M | 0.43% | 27 |
|
|
2020
Q2 | $1.7B | Sell |
12,063,878
-1,839,717
| -13% | -$268M | 0.52% | 22 |
|
|
2020
Q1 | $1.82B | Sell |
13,903,595
-3,300,136
| -19% | -$468M | 0.64% | 14 |
|
|
2019
Q4 | $2.51B | Buy |
17,203,731
+3,114,673
| +22% | +$422M | 0.64% | 14 |
|
|
2019
Q3 | $1.82B | Buy |
14,089,058
+332,571
| +2% | +$43.8M | 0.53% | 17 |
|
|
2019
Q2 | $1.92B | Buy |
13,756,487
+173,875
| +1% | +$24.1M | 0.55% | 15 |
|
|
2019
Q1 | $1.9B | Sell |
13,582,612
-2,046,196
| -13% | -$274M | 0.57% | 15 |
|
|
2018
Q4 | $2.02B | Buy |
15,628,808
+508,179
| +3% | +$70.9M | 0.64% | 15 |
|
|
2018
Q3 | $2.09B | Buy |
15,120,629
+814,920
| +6% | +$108M | 0.54% | 17 |
|
|
2018
Q2 | $1.74B | Sell |
14,305,709
-1,706,293
| -11% | -$213M | 0.47% | 21 |
|
|
2018
Q1 | $2.05B | Buy |
16,012,002
+92,126
| +0.6% | +$12.5M | 0.52% | 18 |
|
|
2017
Q4 | $2.22B | Buy |
15,919,876
+1,712,717
| +12% | +$239M | 0.53% | 16 |
|
|
2017
Q3 | $1.85B | Buy |
14,207,159
+329,749
| +2% | +$43.7M | 0.45% | 20 |
|
|
2017
Q2 | $1.84B | Buy |
13,877,410
+1,748,151
| +14% | +$223M | 0.48% | 18 |
|
|
2017
Q1 | $1.51B | Buy |
12,129,259
+1,776,657
| +17% | +$212M | 0.41% | 27 |
|
|
2016
Q4 | $1.19B | Buy |
10,352,602
+483,673
| +5% | +$55.9M | 0.34% | 31 |
|
|
2016
Q3 | $1.17B | Sell |
9,868,929
-1,250,835
| -11% | -$152M | 0.35% | 29 |
|
|
2016
Q2 | $1.35B | Buy |
11,119,764
+378,878
| +4% | +$43.1M | 0.44% | 18 |
|
|
2016
Q1 | $1.16B | Sell |
10,740,886
-3,158,217
| -23% | -$327M | 0.38% | 23 |
|
|
2015
Q4 | $1.43B | Buy |
13,899,103
+2,235,039
| +19% | +$225M | 0.45% | 18 |
|
|
2015
Q3 | $1.09B | Sell |
11,664,064
-1,575,589
| -12% | -$152M | 0.37% | 28 |
|
|
2015
Q2 | $1.29B | Buy |
13,239,653
+1,700,452
| +15% | +$170M | 0.4% | 25 |
|
|
2015
Q1 | $1.16B | Buy |
11,539,201
+1,831,473
| +19% | +$186M | 0.37% | 23 |
|
|
2014
Q4 | $1.02B | Buy |
9,707,728
+1,601,199
| +20% | +$169M | 0.32% | 31 |
|
|
2014
Q3 | $864M | Sell |
8,106,529
-2,409,807
| -23% | -$250M | 0.27% | 48 |
|
|
2014
Q2 | $1.1B | Buy |
10,516,336
+830,291
| +9% | +$83.9M | 0.34% | 34 |
|
|
2014
Q1 | $951M | Sell |
9,686,045
-763,790
| -7% | -$70.8M | 0.31% | 42 |
|
|
2013
Q4 | $957M | Buy |
10,449,835
+2,052,379
| +24% | +$189M | 0.31% | 41 |
|
|
2013
Q3 | $728M | Sell |
8,397,456
-12,845,542
| -60% | -$1.15B | 0.27% | 53 |
|
|
2013
Q2 | $1.82B | Buy |
+21,242,998
| New | +$1.8B | 0.7% | 12 |
|
Other funds holding JNJ
VCM
VPM
Goldman Sachs's JNJ Position: Q1 2026 in Review
Goldman Sachs increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $400M and bringing the position to 18,057,047 shares worth $4.41B. The position accounts for 0.51% of the portfolio, ranked #24.
Goldman Sachs first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Goldman Sachs held 18,057,047 shares of Johnson & Johnson worth $4.41B as of Q1 2026.
- Goldman Sachs bought 1,716,975 Johnson & Johnson shares in Q1 2026, an estimated $400M.
- Johnson & Johnson made up 0.51% of Goldman Sachs's portfolio in Q1 2026, its #24 holding.
- Goldman Sachs first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.